Susquehanna International Group, LLP Vaxart, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.58 - $0.99 $34,220 - $58,410	-59,000 Reduced 38.51%	94,200 $80,000
Q2 2024 Aug 15, 2024	BUY	$0.53 - $1.3 $70,649 - $173,290	133,300 Added 669.85%	153,200 $102,000
Q1 2024 May 07, 2024	BUY	$0.56 - $1.41 $11,144 - $28,059	19,900 New	19,900 $25,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $1,620 - $3,807	2,700 Added 10.23%	29,100 $21,000
Q1 2023 May 16, 2023	BUY	$0.71 - $1.25 $426 - $750	600 Added 2.33%	26,400 $20,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $133,050 - $397,376	-177,400 Reduced 87.3%	25,800 $24,000
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $65,626 - $141,300	-31,400 Reduced 13.38%	203,200 $443,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.